MP faculty publications from May 2019

1. Resolution of Gastric Cancer-Promoting Inflammation: A Novel Strategy for Anti-cancer Therapy.

   Piazuelo MB, Riechelmann RP, Wilson KT, Algood HMS
   Curr Top Microbiol Immunol. 2019;421:319-359

2. A Clinical Review of Diabetic Foot Infections.

   Chastain CA, Klopfenstein N, Serezani CH, Aronoff DM
   Clin Podiatr Med Surg. 2019 Jul;36(3):381-395

3. High prevalence of Group B Streptococcus colonization among pregnant women in Amman, Jordan.

   Clouse K, Shehabi A, Suleimat AM, Faouri S, Khuri-Bulos N, Al Jammal A, Chappell J, Fortner KB, Chamby AB, Randis TM, Ratner AJ, Aronoff DM, Halasa N
   BMC Pregnancy Childbirth. 2019 May 20;19(1):177

4. MicroLESA: Integrating Autofluorescence Microscopy, In Situ Micro-Digestions, and Liquid Extraction Surface Analysis for High Spatial Resolution Targeted Proteomic Studies.

   Ryan DJ, Patterson NH, Putnam NE, Wilde AD, Weiss A, Perry WJ, Cassat JE, Skaar EP, Caprioli RM, Spraggins JM
   Anal Chem. 2019 May 31;:

5. The Salivary Microbiome Is Altered in Children With Eosinophilic Esophagitis and Correlates With Disease Activity.

   Hiremath G, Shilts MH, Boone HH, Correa H, Acra S, Tovchigrechko A, Rajagopala SV, Das SR
   Clin Transl Gastroenterol. 2019 May 20;:

6. Effect of environmental salt concentration on the Helicobacter pylori exoproteome.

   Caston RR, Loh JT, Voss BJ, McDonald WH, Scholz MB, McClain MS, Cover TL
   J Proteomics. 2019 May 04;:

7. In Situ Molecular Architecture of the Helicobacter pylori Cag Type IV Secretion System.

   Hu B, Khara P, Song L, Lin AS, Frick-Cheng AE, Harvey ML, Cover TL, Christie PJ
   MBio. 2019 May 14;10(3):

8. Broadly neutralizing antibodies targeting new sites of vulnerability in hepatitis C virus E1E2.

   Colbert MD, Flyak AI, Ogega CO, Kinchen VJ, Massaccesi G, Hernandez M, Davidson E, Doranz BJ, Cox AL, Crowe JE, Bailey JR
   J Virol. 2019 May 08;:

9. A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.

   Bangaru S, Lang S, Schotsaert M, Vanderven HA, Zhu X, Kose N, Bombardi R, Finn JA, Kent SJ, Gilchuk P, Gilchuk I, Turner HL, García-Sastre A, Li S, Ward AB, Wilson IA, Crowe JE
   Cell. 2019 May 16;

10. A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection.

    Kose N, Fox JM, Sapparapu G, Bombardi R, Tennekoon RN, de Silva AD, Elbashir SM, Theisen MA, Humphris-Narayanan E, Ciaramella G, Himansu S, Diamond MS, Crowe JE
    Sci Immunol. 2019 May 17;4(35):

11. Nucleoside analogues for the treatment of coronavirus infections.

    Pruijssers AJ Denison MR
    Curr Opin Virol. 2019 May 21;35:57-62

12. Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope.

    Schoofs T, Barnes CO, Suh-Toma N, Golijanin J, Schommers P, Gruell H, West AP, Bach F, Lee YE, Nogueira L, Georgiev IS, Bailer RT, Czartoski J, Mascola JR, Seaman MS, McElrath MJ, Doria-Rose NA, Klein F, Nussenzweig MC, Bjorkman PJ
    Immunity. 2019 May 14;:

13. Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model.

    Goettel JA, Kotlarz D, Emani R, Canavan JB, Konnikova L, Illig D, Frei SM, Field M, Kowalik M, Peng K, Gringauz J, Mitsalis V, Wall SM, Tsou A, Griffith AE, Friedman JR, Towne JE, Plevy SE, O'Hara Hall A, Snapper SB
    Cell Mol Gastroenterol Hepatol. 2019 May 09;:

14. GCH1 haplotypes and cardiovascular risk in HIV.

    Slaven JE, Haas DW, Liu Z, Stein JH, Brown TT, Gupta SK
    AIDS. 2019 May 09;:

15. Picturing Polarized Myeloid Phagocytes and Regulatory Cells by Mass Cytometry.

    Roussel M, Bartkowiak T, Irish JM
    Methods Mol Biol. 2019;1989:217-226

16. Control of antiviral innate immune response by protein geranylgeranylation.

    Yang S, Harding AT, Sweeney C, Miao D, Swan G, Zhou C, Jiang Z, Fitzgerald KA, Hammer G, Bergo MO, Kroh HK, Lacy DB, Sun C, Glogauer M, Que LG, Heaton NS, Wang D
    Sci Adv. 2019 May;5(5):eaav7999

17. FcγRIIb on CD11c+ cells modulates serum cholesterol and triglyceride levels and differentially affects atherosclerosis in male and female Ldlr-/- mice.

    Marvin J, Rhoads JP, Major AS
    Atherosclerosis. 2019 Apr 13;285:108-119

18. Widespread Tau-Specific CD4 T Cell Reactivity in the General Population.

    Lindestam Arlehamn CS, Pham J, Alcalay RN, Frazier A, Shorr E, Carpenter C, Sidney J, Dhanwani R, Agin-Liebes J, Garretti F, Amara AW, Standaert DG, Phillips EJ, Mallal SA, Peters B, Sulzer D, Sette A
    J Immunol. 2019 May 13;:

19. A Rapid Allele-Specific Assay for HLA-A*32:01 to Identify Patients at Risk for Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms.

    Rwandamuriye FX, Chopra A, Konvinse KC, Choo L, Trubiano JA, Shaffer CM, Watson M, Mallal SA Phillips EJ
    J Mol Diagn. 2019 May 31;:

20. B lymphocytes protect islet β cells in diabetes prone NOD mice treated with imatinib.

    Wilson CS, Spaeth JM, Karp J, Stocks BT, Hoopes EM, Stein RW, Moore DJ
    JCI Insight. 2019 Apr 09;5:

21. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison to GCK-MODY (MODY2).

    Gregory JM, Smith TJ, Slaughter JC, Mason HR, Hughey CC, Smith MS, Kandasamy B, Greeley SAW, Philipson LH, Naylor RN, Letourneau LR, Abumrad NN, Cherrington AD, Moore DJ
    Diabetes. 2019 May 15;:

22. Regulation of Diabetogenic Immunity by IL15-Activated Regulatory CD8 T Cells in Type 1 Diabetes.

    Stocks BT, Wilson CS, Marshall AF, Hoopes EM, Moore DJ
    J Immunol. 2019 May 24;:

23. VacA generates a protective intracellular reservoir for Helicobacter pylori that is eliminated by activation of the lysosomal calcium channel TRPML1.

    Capurro MI, Greenfield LK, Prashar A, Xia S, Abdullah M, Wong H, Zhong XZ, Bertaux-Skeirik N, Chakrabarti J, Siddiqui I, O'Brien C, Dong X, Robinson L, Peek RM, Philpott DJ, Zavros Y, Helmrath M, Jones NL
    Nat Microbiol. 2019 May 20;:

24. Modification of the Gastric Mucosal Microbiota by a Strain-Specific Helicobacter pylori Oncoprotein and Carcinogenic Histologic Phenotype.

    Noto JM, Zackular JP, Varga MG, Delgado A, Romero-Gallo J, Scholz MB, Piazuelo MB, Skaar EP, Peek RM
    MBio. 2019 May 28;10(3):

25. Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T cell efficacy.

    van Bruggen JAC, Martens AWJ, Fraietta JA, Hofland T, Tonino SH, Eldering E, Levin MD, Siska PJ, Endstra S, Rathmell JC, June CH, Porter DL, Melenhorst JJ, Kater AP, van der Windt GJW
    Blood. 2019 May 10;:

26. Probiotics Modulate a Novel Amphibian Skin Defense Peptide That Is Antifungal and Facilitates Growth of Antifungal Bacteria.

    Woodhams DC, Rollins-Smith LA, Reinert LK, Lam BA, Harris RN, Briggs CJ, Vredenburg VT, Patel BT, Caprioli RM, Chaurand P, Hunziker P, Bigler L
    Microb Ecol. 2019 May 16;:

27. Correction to: Intervertebral disc penetration by antibiotics used prophylactically in spinal surgery: implications for the current standards and treatment of disc infections.

    Capoor MN, Lochman J, McDowell A, Schmitz JE, Solansky M, Zapletalova M, Alamin TF, Coscia MF, Garfin SR, Jancalek R, Ruzicka F, Shamie AN, Smrcka M, Wang JC, Birkenmaier C, Slaby O
    Eur Spine J. 2019 May 27;:

28. Comparison of different dosage regimes of epsilon aminocaproic acid on blood loss in children undergoing craniosynostosis surgery.

    Nguyen TT, Lam HV, Austin TM, Stricker P, Tunceroglu H, Schoenecker J
    Paediatr Anaesth. 2019 May 29;:

29. Monophosphoryl Lipid A Attenuates Multiorgan Dysfunction During Post-Burn Pseudomonas Aeruginosa Pneumonia In Sheep.

    Fukuda S, Ihara K, Bohannon JK, Hernandez A, Patil NK, Luan L, Stothers C, Stark R, Prough DS, Herndon DN,Sherwood ER, Enkhbaatar P
    Shock. 2019 Apr 26;:

30. Loss of monocyte metabolic plasticity in endotoxin tolerance: A model for understanding sepsis-induced immune paralysis?

    Williams DL, Li C, Sherwood ER
    J Leukoc Biol. 2019 May 14;:

31. Metals as phagocyte antimicrobial effectors.

    Sheldon JR, Skaar EP
    Curr Opin Immunol. 2019 May 04;60:1-9

32. Targeting Mobilization of Ferrous Iron in Pseudomonas aeruginosa Infection with an Iron(II)-Caged LpxC Inhibitor.

    Blank B, Talukder P, Muir R, Green E, Skaar EP, Renslo AR
    ACS Infect Dis. 2019 May 29;:

33. A non-circulating pool of factor XI associated with glycosaminoglycans in mice.

    Mohammed BM, Cheng Q, Matafonov A, Verhamme IM, Emsley J, McCrae KR, McCarty OJT, Gruber A, Gailani D
    J Thromb Haemost. 2019 May 24;:

34. Correction: Kaiso is required for MTG16-dependent effects on colitis-associated carcinoma.

    Short SP, Barrett CW, Stengel KR, Revetta FL, Choksi YA, Coburn LA, Lintel MK, McDonough EM, Washington MK, Wilson KT, Prokhortchouk E, Chen X, Hiebert SW, Reynolds AB, Williams CS
    Oncogene. 2019 May 08;:

35. Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low-resource Central America setting.

    Ortiz V, Estevez-Ordonez D, Montalvan-Sanchez E, Urrutia-Argueta S, Israel D, Krishna US, Romero-Gallo J, Wilson KT, Peek RM, Dominguez R, Morgan DR
    Helicobacter. 2019 May 20;:e12595

36. Identification of novel susceptibility loci and genes for prostate cancer risk: A transcriptome-wide association study in over 140,000 European descendants.

    Wu L, Wang J, Cai Q, Cavazos TB, Emami NC, Long J, Shu XO, Lu Y, Guo X, Bauer JA, Pasaniuc B, Penney KL, Freedman ML, CRUK, BPC3, CAPS, PEGASUS consortia PRACTICAL, Kote-Jarai Z, Witte JS, Haiman CA, Eeles RA, Zheng W
    Cancer Res. 2019 May 17;:

37. The importance of developing therapies targeting the biological spectrum of metastatic disease.

    Zijlstra A, Von Lersner A, Yu D, Borrello L, Oudin M, Kang Y, Sahai E, Fingleton B, Stein U, Cox TR, Price JT, Kato Y, Welm AL, Aguirre-Ghiso JA, Board Members of the Metastasis Research Society
    Clin Exp Metastasis. 2019 May 17;: